Treatment for Inflammation and Pain with Reduced Gastro-Intestinal Side Effects Combining Methylprednisolone, Paracetamol, and Lansoprazole
OwnerGeorgiy Brusovanikinventor
Life of this patent
Estimating the term…
Abstract
A multimodal treatment for inflammation and pain with reduced gastro-intestinal side effects combines an anti-inflammatory, an analgesic, and a composition for reducing stomach acid. A preferred composition utilizes a steroid as the anti-inflammatory and a proton inhibitor as the composition for reducing stomach acid. A composition including methylprednisolone as the anti-inflammatory, paracetamol as the analgesic, and esomeprazole or lansoprazole as the composition for reducing stomach acid is particularly effective. The composition can be combined into a single pill for more convenient and controlled delivery. The treatment can be used to treat joint pain, particularly back and neck pain.
Claims23
A treatment for inflammation and pain, comprising:
- an anti-inflammatory;
- an analgesic;
- and
- a composition for reducing stomach acid.
A course of treatment for inflammation and pain, comprising:
- a first dose to be given at a first time, said first dose including:
- a therapeutic amount of methylprednisolone;
- a therapeutic amount of paracetamol;
- a therapeutic amount of lansoprazole;
- and
- a delivery mechanism for controlling at least one of an amount and a duration of a delivery of one of said methylprednisolone, said paracetamol, and said lansoprazole so that when a second dose is given at a second time, said methylprednisolone, said paracetamol, and said lansoprazole all remain at a therapeutic level between said first time and said second time and at a safe level after said second time;
- and
- said second dose to be given at said second time, said second dose including at least one of:
- a therapeutic amount of methylprednisolone;
- a therapeutic amount of paracetamol;
- and
- a therapeutic amount of lansoprazole.
A method of treating inflammation and pain while reducing gastro-intestinal side effects, which comprises:
- providing a therapeutic amount of an anti-inflammatory;
- providing a therapeutic amount of an analgesic;
- and
- providing a therapeutic amount of a stomach acid reducer.
A method for treating inflammation and pain while reducing gastro-intestinal side effect over a course of treatment, which comprises:
- delivering a first dose at a start of said course, said first dose including a therapeutically effective amount of an anti-inflammatory, a therapeutically effective amount of an analgesic, and a therapeutically effective amount of a composition for reducing stomach acid;
- delivering a second dose at a second time during said course, said second dose including at least one of a therapeutically effective amount of an anti-inflammatory, a therapeutically effective amount of an analgesic, and a therapeutically effective amount of a composition for reducing stomach acid;
- prolonging treatment of the inflammation and the pain while reducing the gastro-intestinal side effects between the start and the second time and while preventing exposure to unsafe amounts of said anti-inflammatories, said analgesics, and said compositions for reducing stomach acid by adjusting at least one of:
- an amount of at least one of said anti-inflammatory, said analgesic, and said composition for reducing stomach acid in said first dose,
- a delivery rate of at least one of said anti-inflammatory, said analgesic, and said composition for reducing stomach acid in said first dose;
- an amount of at least one of said anti-inflammatory, said analgesic, and said composition for reducing stomach acid in said second dose, and
- a delivery rate of at least one of said anti-inflammatory, said analgesic, and said composition for reducing stomach acid in said second dose.
Dependencies are inferred from the claim text.